Market News
BioLineRx (BLRX): Q3 2019 Earnings Snapshot
— BiolineRX (NASDAQ: BLRX) reported third quarter 2019 operating loss of $6.6 million vs. $6.2 million loss in the year-over period. — Net loss per…